Marc André Ceusters
11Patents
2h-index
16Co-inventors
51Inventor score
Filing activity: Jul 21, 1997 → Aug 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9708315B2 | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors | Human Necessities | 3 | Active |
| US5952464A | Labelled peptide compounds | Human Necessities | 2 | Expired |
| US6194386A | Labelled peptide compounds | Human Necessities | 2 | Expired |
| US7208503B2 | Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives | Chemistry; Metallurgy | 2 | Expired |
| US6602873B2 | Angiogenesis inhibiting thiadiazolyl pyridazine derivatives | Chemistry; Metallurgy | 2 | Expired |
| US11369606B2 | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | Human Necessities | 1 | Active |
| US10537573B2 | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | Human Necessities | 1 | Active |
| US6265407A | Angiogenesis inhibiting thiadiazolyl pyridazine derivatives | Chemistry; Metallurgy | 1 | Expired |
| US12048696B2 | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | Human Necessities | 0 | Active |
| US6833369B2 | Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives | Chemistry; Metallurgy | 0 | Expired |
| US11103506B2 | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.